Patents by Inventor James Berger Camden

James Berger Camden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5770616
    Abstract: A pharmaceutical composition that inhibits the growth of tumors and cancers in mammals that comprises a material is disclosed. The particular material used is a 1H-1,2,4-triazole derivative. These compounds can also be used to treat viral infections.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: June 23, 1998
    Assignee: The Procter & Gamble Company
    Inventor: James Berger Camden
  • Patent number: 5767138
    Abstract: A pharmaceutical composition that inhibits the growth of tumors and cancers in mammals and can be used to treat viral infections that comprises a fungicide is disclosed. The particular fungicide used is a benzimidazole derivative.
    Type: Grant
    Filed: December 20, 1996
    Date of Patent: June 16, 1998
    Assignee: Procter & Gamble Company
    Inventor: James Berger Camden
  • Patent number: 5665751
    Abstract: A pharmaceutical composition that inhibits the growth of tumors and cancers in mammals comprising fungicide is disclosed. The particular fungicide used is a 1,3-bis-triazolyl-2-propanol derivative. These compositions are also effective against viral infections.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 9, 1997
    Assignee: The Procter & Gamble Company
    Inventor: James Berger Camden
  • Patent number: 5665713
    Abstract: This invention is a pharmaceutical composition that inhibits the growth of cancers and tumors in mammals, particularly in human and warm blooded animals. The composition is also effective against viruses. The composition contains N-phosphonoglycine derivatives which are systemic herbicides.
    Type: Grant
    Filed: April 12, 1995
    Date of Patent: September 9, 1997
    Assignee: Procter & Gamble Company
    Inventor: James Berger Camden
  • Patent number: 5656615
    Abstract: This invention is a pharmaceutical composition that inhibits the growth of cancers and tumors in mammals, particularly in human and warm blooded animals. The composition contains a 10:1 to 1:10 mixture of (1) N-chlorophenyl carbamates and N-chlorophenylthiocarbamates and (2) N-phosphonoglycine derivatives which are systemic herbicides. This composition can also be used to treat viral infections.
    Type: Grant
    Filed: April 12, 1995
    Date of Patent: August 12, 1997
    Assignee: The Procter & Gamble Company
    Inventor: James Berger Camden